Over recent decades, it has become clear that epigenetic abnormalities are involved in the hallmarks of cancer. Histone modifications, such as acetylation, play a crucial role in cancer development and progression, by regulating gene expression, such as for oncogenes or tumor suppressor genes. Therefore, histone deacetylase inhibitors (HDACi) have recently shown efficacy against both hematological and solid cancers. Designed to target histone deacetylases (HDAC), these drugs can modify the expression pattern of numerous genes including those coding for micro-RNAs (miRNA). miRNAs are small non-coding RNAs that regulate gene expression by targeting messenger RNA. Current research has found that miRNAs from a tumor can be investigated in the tumor itself, as well as in patient body fluids. In this review, we summarized current knowledge about HDAC and HDACi in several cancers, and described their impact on miRNA expression. We discuss briefly how circulating miRNAs may be used as biomarkers of HDACi response and used to investigate response to treatment.
Keywords: HDAC inhibitors; cancer; exosome; microRNA.
Conflict of interest statement
The authors declare no conflict of interest.
HDACs and HDAC Inhibitors in Cancer Development and TherapyY Li et al. Cold Spring Harb Perspect Med 6 (10). PMID 27599530. - ReviewOver the last several decades, it has become clear that epigenetic abnormalities may be one of the hallmarks of cancer. Posttranslational modifications of histones, for e …
Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A ReviewSR Ali et al. Drug Dev Res 76 (6), 296-317. PMID 26303212. - ReviewChromatin-modifying drugs, such as histone deacetylase inhibitors (HDACi), have shown potential as cancer therapeutics, either alone or in combination with other therapie …
HTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis Vinifera) in HeLa CellsEA Mazzio et al. Cancer Genomics Proteomics 14 (1), 17-33. PMID 28031235.The data from this study show that plant- based HDACis are relatively rare, and can elicit a similar pattern to TSA in up-regulating miRNAs involved with tumor suppressio …
Epigenetic Alterations and microRNA Misexpression in Cancer and Autoimmune Diseases: A Critical ReviewY Saito et al. Clin Rev Allergy Immunol 47 (2), 128-35. PMID 24362548. - ReviewEpigenetic markers such as DNA methylation and histone modifications around promoter regions modify chromatin structure and regulate expression of downstream genes. In fa …
Targeting Histone Deacetylases in Diseases: Where Are We?R Benedetti et al. Antioxid Redox Signal 23 (1), 99-126. PMID 24382114. - ReviewSelective HDACi could achieve enhanced clinical utility by reducing or eliminating the serious side effects associated with current first-generation non-selective HDACi. …